Cancer Clinical Investigation

Search results

• -Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103, A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer

  Galsky, M.

  2/04/24

  2 items of Media coverage

  Press/Media

• Cellenkos links with Mount Sinai to explore CK0804 for myelofibrosis

  Hoffman, R.

  2/04/24

  1 item of Media coverage

  Press/Media

• Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer

  Galsky, M.

  1/04/24

  8 items of Media coverage

  Press/Media

• Cellenkos® Enters Into Sponsored Research Agreement With Icahn School Of Medicine At Mount Sinai, New York.

  Hoffman, R.

  1/04/24

  1 item of Media coverage

  Press/Media

• Cellenkos® enters into Sponsored Research Agreement with Icahn School of Medicine at Mount Sinai, New York.

  Hoffman, R.

  1/04/24

  74 items of Media coverage

  Press/Media

• Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer

  Galsky, M.

  1/04/24

  1 item of Media coverage

  Press/Media

• Researchers from Icahn School of Medicine at Mount Sinai Publish New Studies and Findings in the Area of Immunotherapy (Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to ...)

  Hirsch, F., Hirsch, F. & de Miguel Perez, D.

  1/04/24

  1 item of Media coverage

  Press/Media

• 08:16 EDT Natera launches Alliance A032103 utilizing Signatera MRD test for MIUC

  Galsky, M.

  1/04/24

  1 item of Media coverage

  Press/Media

• Data on Kidney Cancer Described by Researchers at Icahn School of Medicine at Mount Sinai (Characterization of Renal Masses With Mri-based Radiomics: Assessment of Inter-package and Inter-observer Reproducibility In a Prospective Pilot Study)

  Badani, K., Lewis, S., Taouli, B., Bane, O. & Horowitz, A.

  1/04/24

  1 item of Media coverage

  Press/Media

• EDAP TMS S.A. (NASDAQ:EDAP) Q4 2023 Earnings Call Transcript

  Tewari, A.

  29/03/24

  3 items of Media coverage

  Press/Media

• Reports from Icahn School of Medicine at Mount Sinai Provide New Insights into Myelofibrosis (Real-world Use of Fedratinib for Myelofibrosis Following Prior Ruxolitinib Failure: Patient Characteristics, Treatment Patterns, and Clinical Outcomes)

  Mascarenhas, J.

  26/03/24

  1 item of Media coverage

  Press/Media

• Non-surgical Options in Bladder Cancer

  Galsky, M.

  21/03/24

  1 item of Media coverage

  Press/Media

• Researchers from Icahn School of Medicine at Mount Sinai Report New Studies and Findings in the Area of Biomarkers (The Utility of Biomarkers In Acute Gvhd Prognostication)

  Levine, J., Etra, A. & Akahoshi, Y.

  19/03/24

  1 item of Media coverage

  Press/Media

• Central Hospital of Wuhan Researchers Detail Findings in Deafness [The clinical and genetic characteristics of maternally inherited diabetes and deafness (MIDD) with mitochondrial m.3243A > G mutation: A 10-year follow-up observation study and ...]

  Wang, P.

  18/03/24

  1 item of Media coverage

  Press/Media

• Game’s afoot in bladder cancer research

  Sfakianos, J. & Galsky, M.

  18/03/24

  1 item of Media coverage

  Press/Media

• Data on Colon Cancer Described by Researchers at Fourth Military Medical University (Mitochondria-targeted photodynamic therapy triggers GSDME-mediated pyroptosis and sensitizes anti-PD-1 therapy in colorectal cancer)

  Wang, P.

  14/03/24

  1 item of Media coverage

  Press/Media

• The 1st International Symposium on Cancer Immunology and Immunotherapy

  Merad, M. & Marron, T.

  13/03/24

  1 item of Media coverage

  Press/Media

• University of Colorado School of Medicine Researchers Update Understanding of Radiation Therapy (Clinical and Dosimetric Impact of 2D kV Motion Monitoring and Intervention in Liver Stereotactic Body Radiation Therapy)

  Goodman, K.

  12/03/24

  1 item of Media coverage

  Press/Media

• Reports from Icahn School of Medicine at Mount Sinai Provide New Insights into Cancer [Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a Cyp3a4 Substrate, Plus Cyp3a4-interacting Antiretroviral Therapy In People Living With Hiv and ...]

  Sparano, J.

  11/03/24

  1 item of Media coverage

  Press/Media

• Novel Treatment for Polycythemia Vera Shows Promise in Clinical Trial

  Ginzburg, Y. & Hoffman, R.

  11/03/24

  1 item of Media coverage

  Press/Media

• Research Results from New York City Update Knowledge of Bladder Cancer (BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer)

  Sfakianos, J.

  5/03/24

  1 item of Media coverage

  Press/Media

• Researchers from Huazhong University of Science and Technology Report on Findings in Cholangitis (Severity Assessment To Guide Empiric Antibiotic Therapy for Cholangitis In Children After Kasai Portoenterostomy: a Multicenter Prospective ...)

  Wang, P.

  1/03/24

  1 item of Media coverage

  Press/Media

• AACR Announces 2024 Scientific Achievement Award Recipients

  Sparano, J.

  28/02/24

  1 item of Media coverage

  Press/Media

• AACR Announces 2024 Scientific Achievement Award Recipients

  Sparano, J.

  27/02/24

  1 item of Media coverage

  Press/Media

• Novel treatment for polycythemia vera shows promise in clinical trial

  Ginzburg, Y., Hoffman, R. & Kremyanskaya, M.

  27/02/24

  2 items of Media coverage

  Press/Media